Pinealon Research: Structure and Laboratory Studies
Research only. All AVM Labs USA products are sold strictly for laboratory research. Nothing on this page is medical advice, and nothing here describes use in humans or animals.
Pinealon is one of the shortest research peptides in the scientific literature: three amino acids, and nothing else. This guide explains it the way the laboratory literature does: its molecular structure, how it is synthesized and characterized, and how to read the studies that mention it.
What Pinealon is, in laboratory terms
Pinealon is a synthetic tripeptide of sequence Glu-Asp-Arg, written EDR in one-letter code. It is one of the short-peptide bioregulators documented in the Russian scientific literature, from the research programme of Vladimir Khavinson and colleagues at the St Petersburg Institute of Bioregulation and Gerontology.
The programme’s working name for the tripeptide is Pinealon; its chemical name is L-glutamyl-L-aspartyl-L-arginine. It was patented in 2006 by Khavinson and colleagues (US 8,524,674, granted 2013).
Pinealon is one of several tripeptides in the programme, each associated with a source tissue. EDR’s association is the pineal gland and brain tissue generally. A search of PubMed found 22 records for Pinealon (searched October 2026), and most of the papers list Khavinson or colleagues from his institute among the authors.
Molecular structure
The reported molecular identity of Pinealon is:
- A three-amino-acid chain — L-glutamic acid, L-aspartic acid and L-arginine, joined by two peptide bonds in the order Glu-Asp-Arg. Written with its free termini as H-Glu-Asp-Arg-OH.
- A molecular formula of C15H26N6O8, with a molecular weight of approximately 418.4 g/mol and a monoisotopic mass of 418.18 Da. In positive-mode mass spectrometry the molecule is observed at m/z 419.2 for the [M+H]+ ion.
- CAS number 175175-23-2, with PubChem CID 10273502 and InChIKey QPRZKNOOOBWXSU-CIUDSAMLSA-N.
- Free termini at both ends — a free amino group at the start of the chain and a free carboxylic acid at the end, with no caps or other modifications.
At approximately 418.4 Da, Pinealon is the smallest peptide in this catalogue, and that mass is the first identity check on a COA.
These are the structural facts a Certificate of Analysis verifies: the sequence, the three residues, and the molecular weight.
How it compares to Epithalon and the other short peptides
Pinealon is usually discussed alongside the other short peptides in the Khavinson programme:
- Pinealon is a tripeptide: Glu-Asp-Arg (EDR), three residues, approximately 418.4 Da, associated with pineal and brain tissue.
- Epithalon is a tetrapeptide: Ala-Glu-Asp-Gly (AEDG), four residues. It is the best-known member of the same programme and the closest structural comparison for Pinealon — one residue longer, with a different first and last residue. Our post on Epithalon Research covers it.
- Vesugen, another tripeptide in the same programme, is Lys-Glu-Asp: one substitution, with lysine rather than arginine at the opposite end of the chain.
- The longer brain peptides in this catalogue — Semax, Selank and Dihexa — are built on different frameworks and studied in different assay systems. Our posts on Semax Research, Selank Research and Dihexa Research cover them.
Three residues or four, arginine or lysine at the end: small structural differences, separate entries in a research catalogue.
How research peptides like Pinealon are made: solid-phase synthesis
Like most research peptides, Pinealon is produced by solid-phase peptide synthesis (SPPS):
- The first amino acid is anchored to a solid resin support.
- Amino acids are added one at a time, in the planned sequence, with the growing chain held on the resin.
- Protecting groups shield the parts of each amino acid that should not react yet, and are removed at the right step.
- The finished chain is cleaved from the resin and purified.
The laboratory controls exactly the same variables as for a longer chain: which amino acids, in which order, and with which stereochemistry. All three residues are the L-form, and that is part of the identity a COA verifies. Our post on peptide synthesis explains this method in detail.
How Pinealon is characterized: identity and purity
A research peptide is not defined by its name alone. In the laboratory it is defined by analytical data, typically:
- Mass spectrometry (MS): confirms the molecular weight matches the intended sequence. For Pinealon the observed mass must read approximately 418.4 Da — a different tripeptide gives a different number, and the [M+H]+ ion at m/z 419.2 is the direct check.
- High-performance liquid chromatography (HPLC): measures purity and reveals impurities, including deletion sequences or incomplete coupling products from synthesis.
- Certificate of Analysis (COA): the laboratory document that reports those results for a specific batch.
When comparing research materials, the COA is the document that matters: same compound, different batch, different data. Our guide on how to read a peptide COA explains what each field on that document means.
How Pinealon is studied in the literature
Laboratory research on Pinealon takes several forms:
- Cell culture studies: measurements in cultured cells under induced oxidative stress, including cerebellar granule cells, neutrophils and PC12 cells (Khavinson, Rejuvenation Research, 2011, PMID 22117547).
- Organotypic cultures: studies in organotypic pineal gland cultures from rats, where the expression of cell markers was measured (Khavinson and colleagues, Bulletin of Experimental Biology and Medicine, 2011).
- Rodent models: studies in rats under models of hypoxia, hypothermia and aging, including work on learning retention in rats with experimentally induced diabetes.
- Mechanism reviews: a 2020 review by Khavinson and colleagues (Molecules) proposes that short peptides like EDR interact directly with DNA and histones, with two possible EDR binding sites, d(CCTGCC)2 and d(CCAGC)2, proposed by molecular modeling. This is a proposed mechanism, not an established one.
The record is preclinical throughout: cultured cells, organotypic organ explants and rodent models, with no part of it conducted in people. Most of the work was done by one research group.
Stability and handling in the laboratory
Peptides are sensitive molecules, and laboratory handling reflects that. The topics researchers document include storage temperature, protection from light and moisture, freeze–thaw cycles, and how long a prepared solution remains stable. Our posts on peptide storage and stability and on refrigeration and shipping cover this in detail.
How to read a Pinealon study
When you open a paper that mentions Pinealon, check four things first:
- What exactly was studied? The compound name, the sequence or identifier (EDR, Glu-Asp-Arg), and the source of the material.
- In what model? Cell culture, organotypic culture, or rodent model — and what that model can and cannot show.
- At what scale? The number of samples, the controls used, and whether the result was reproduced.
- Who funded it, and where was it published? Peer review and disclosure are part of the evidence, not decoration.
For the general background, start with What Are Peptides?
Related research on this blog
- Epithalon Research — the tetrapeptide AEDG from the same programme, the closest structural comparison: epithalon-research
- Semax Research — a longer brain peptide studied in the same field: semax-research
- Selank Research — a longer brain peptide studied in the same field: selank-research
- Dihexa Research — a brain peptide studied in the same field: dihexa-research
- Cerebrolysin Research — a brain-derived peptide preparation: cerebrolysin-research
Glossary
- Tripeptide: a peptide of three amino acid residues, joined by two peptide bonds.
- EDR: the one-letter code for Glu-Asp-Arg, the sequence of Pinealon.
- Bioregulator: the programme’s name for its family of very short synthetic peptides.
- Organotypic culture: a laboratory culture of a thin slice of an organ, kept alive outside the body.
- SPPS: solid-phase peptide synthesis, the standard laboratory method for building peptides.
- HPLC: high-performance liquid chromatography, used to measure purity.
- Mass spectrometry (MS): used to confirm molecular weight and identity.
- COA: Certificate of Analysis, the batch document reporting analytical results.
- In vitro: experiments outside a living organism, e.g. in cell culture.
Frequently asked questions (research framing)
What does EDR mean?
It is the one-letter code for the sequence: E for glutamic acid, D for aspartic acid, R for arginine. The full name is L-glutamyl-L-aspartyl-L-arginine, with free termini at both ends.
How is Pinealon different from Epithalon?
They come from the same research programme, but Pinealon is a tripeptide (Glu-Asp-Arg, approximately 418.4 Da) while Epithalon is a tetrapeptide (Ala-Glu-Asp-Gly).
What does a COA tell me?
It reports the analytical results — identity and purity — for one specific batch, measured by the laboratory that tested it. For Pinealon, the key identity checks are the three-residue sequence, the L-form of each residue, and the molecular weight of approximately 418.4 Da.
Where can I learn more?
Start with the posts linked above, and read the primary literature they cite.
Research only. AVM Labs USA products are for laboratory research use only.
